[go: up one dir, main page]

FR3034023B1 - Dispositif de traitement cutane - Google Patents

Dispositif de traitement cutane Download PDF

Info

Publication number
FR3034023B1
FR3034023B1 FR1552380A FR1552380A FR3034023B1 FR 3034023 B1 FR3034023 B1 FR 3034023B1 FR 1552380 A FR1552380 A FR 1552380A FR 1552380 A FR1552380 A FR 1552380A FR 3034023 B1 FR3034023 B1 FR 3034023B1
Authority
FR
France
Prior art keywords
active layer
treatment device
skin treatment
layer
face
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1552380A
Other languages
English (en)
Other versions
FR3034023A1 (fr
Inventor
Jean-Laurent Houot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lucibel SA
Original Assignee
Lucibel SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lucibel SA filed Critical Lucibel SA
Priority to FR1552380A priority Critical patent/FR3034023B1/fr
Publication of FR3034023A1 publication Critical patent/FR3034023A1/fr
Application granted granted Critical
Publication of FR3034023B1 publication Critical patent/FR3034023B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0616—Skin treatment other than tanning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
    • A61N2005/0645—Applicators worn by the patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/065—Light sources therefor
    • A61N2005/0651—Diodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A61N2005/0663—Coloured light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicinal Preparation (AREA)

Abstract

Le dispositif (10) est un patch comprenant une couche active (12) en matériau silicone incorporant un principe actif à effet cosmétique ou pharmaceutique. Cette couche (12) présente une face, dite face de contact (12A), destinée à venir en contact avec la peau d'un utilisateur et un substrat (14) en élastomère portant la couche active (12) et incorporant dans sa masse une source lumineuse (16) à diode électroluminescente (18) d'émission d'un flux lumineux au travers de la couche active (12). La couche active (12) est fixée de manière détachable au substrat (14) par des moyens de liaison amovibles complémentaires (26) aptes à rendre la couche active (12) interchangeable.
FR1552380A 2015-03-23 2015-03-23 Dispositif de traitement cutane Active FR3034023B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1552380A FR3034023B1 (fr) 2015-03-23 2015-03-23 Dispositif de traitement cutane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1552380A FR3034023B1 (fr) 2015-03-23 2015-03-23 Dispositif de traitement cutane

Publications (2)

Publication Number Publication Date
FR3034023A1 FR3034023A1 (fr) 2016-09-30
FR3034023B1 true FR3034023B1 (fr) 2021-01-08

Family

ID=53404715

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1552380A Active FR3034023B1 (fr) 2015-03-23 2015-03-23 Dispositif de traitement cutane

Country Status (1)

Country Link
FR (1) FR3034023B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3137298B1 (fr) 2022-07-04 2025-10-03 Lucibel Sa Insert diffusant la lumière pour le traitement par photothérapie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060173514A1 (en) * 2005-02-02 2006-08-03 Advanced Photodynamic Technologies, Inc. Wound treatment device for photodynamic therapy and method of using same
US20070233208A1 (en) * 2006-03-28 2007-10-04 Eastman Kodak Company Light therapy bandage with imbedded emitters
EP2691114A1 (fr) * 2011-03-29 2014-02-05 Principium Europe S.r.l. Libération de substances biologiquement actives de masse moléculaire élevée
FR2986156B1 (fr) * 2012-01-30 2014-07-04 Rhenovia Pharma Dispositif transdermique pour l'administration controlee a un patient d'au moins un principe actif

Also Published As

Publication number Publication date
FR3034023A1 (fr) 2016-09-30

Similar Documents

Publication Publication Date Title
AR118559A2 (es) Anticuerpos anti-pd-l1 y su uso para mejorar la función de las células t
EA202091615A1 (ru) Интраназальные составы на основе эпинефрина и способы лечения заболевания
BR112017008265A2 (pt) dispositivo emissor de luz sem uso das mãos e sistema de crescimento capilar para uso em um couro cabeludo humano com cabelo
CL2016000866A1 (es) Forma salina de hidrocloruro para la inhibición de ezh2
MA49508B1 (fr) Procédés de traitement d'une insuffisance cardiaque avec des activateurs de sarcomères cardiaques
EA200800782A1 (ru) ПРОИЗВОДНЫЕ АМИДА И КАРБАМАТА N-{2-[4-АМИНО-2-(ЭТОКСИМЕТИЛ)-1Н-ИМИДАЗОЛО[4,5-c]ХИНОЛИН-1-IL]-1,1-ДИМЕТИЛЭТИЛ}МЕТАНСУЛЬФОНАМИДА И СПОСОБЫ
CL2021000847A1 (es) Extracción de fluidos catameniales.
FR3043576B1 (fr) Dispositif miniaturise de pulverisation a transducteur piezoelectrique
GT201700179A (es) Formulaciones en polvo nasal para el tratamiento de hipoglicemia
AR111360A1 (es) Tratamiento usando células t de receptor quimérico incorporando células t polifuncionales optimizadas
CO2021016619A2 (es) Anticuerpos de receptor de péptido natriurético 1 y métodos de uso
MA43615A1 (fr) Dispositif d'injection motorisé pour administrer de multiples formulations liquides, y compris des vaccins
EP3458163C0 (fr) Dispositif de distribution séparée de matériaux à utiliser ensemble sur la peau humaine
CO6640324A2 (es) Uso de metformina en combinación con un activador de glucoquinasa y composiciones que comprenden metformina y un activador de glucoquinasa
JOP20220160A1 (ar) مركبات فعّالة نحو مستقبلات نووية
EA201892443A1 (ru) Фармацевтические композиции и режимы дозирования для клинического использования антител против антигена 2 дендритных клеток крови
MA43767B1 (fr) Anticorps non antagonistes dirigés contre la chaine alpha du domaine extracellulaire du récepteur de l'il-7 et leur utilisation dans le traitement du cancer
CL2020002650A1 (es) Enzimas quinureninasa humanas y sus usos
FR3034023B1 (fr) Dispositif de traitement cutane
MX2021005054A (es) Sistema y metodo de monitoreo del uso de dispositivos medicos.
EP3452533A4 (fr) Poudre de diffusion de lumière, résine photosensible contenant des points quantiques, et film de couleur contenant des points quantiques, et procédés de préparation
EA200900254A1 (ru) Производные 1h-индол-2-карбоновой кислоты, полезные в качестве модуляторов ppar
BR112014011761A2 (pt) sistemas dispensadores de gel para cuidados orais
BR112019001082A2 (pt) gel intestinal de levodopa e carbidopa e métodos de uso
Khan et al. Secretion of total solids (solutes) in the saliva of long-term tobacco users.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20160930

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

CA Change of address

Effective date: 20250617